The Guest Hospital

Details

Name :

The Guest Hospital

Address  :

372 Poonamalle High
Road, Kilpauk

Town  :

Chennai

State  :

Tamil Nadu

Country  :

INDIA

Post Code:

600010

Phone  :

91 044 2641 3420

Web URL  :

Specialization
  • Anaesthesiology
  • Cardiology
  • Cosmetic Surgery
  • Daibetes, Endocrinology
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Microbiology
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Paediatrics
  • Plastic Surgery
  • Urology
  • Vascular Surgeon
Facilities

ICU Beds : 9

Other Facilities

  • X-Ray

Description

About US
The Guest Hospital has been functioning since 1980 and has carved a niche in the field of Urology Nephrology and Kidney Transplant Services for the last three decades We have a group of well qualified highly committed band of professionals to head all our specialty sections

Our operation theatre complex of three major operation theatres and one minor operation theatre is well equipped to handle efficiently all major surgeries Our minimally invasive centre provides the latest treatment using laparoscopy and lasers to ensure prompt recovery and minimal postoperative discomfort Modern nine bedded intensive care unit provides the best possible care for the critically ill patients

Our aim since inception is to provide state of the art quality healthcare at an affordable cost so as to bring the benefits of modern medicine within the reach of everyone In todays world of ever increasing cost of healthcare our aim is more relevant today than ever in the past
India has highest oral cancer cases tobacco guilty areca nut too

India has the dubious distinction of having the worlds largest number of oral cancer patients with an annual agestandardised incidence of 125 per 100000 says Dr Pankaj Chaturvedi Associate Professor Department of Head and Neck Oncology Tata Memorial Hospital Mumbai Oral cancer accounts for 94 per cent of all cancers in India oral cancer is not ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More